BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30670820)

  • 1. Rare ribosomopathies: insights into mechanisms of cancer.
    Aspesi A; Ellis SR
    Nat Rev Cancer; 2019 Apr; 19(4):228-238. PubMed ID: 30670820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosomopathies and the paradox of cellular hypo- to hyperproliferation.
    De Keersmaecker K; Sulima SO; Dinman JD
    Blood; 2015 Feb; 125(9):1377-82. PubMed ID: 25575543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies.
    Venturi G; Montanaro L
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired ribosomopathies in leukemia and solid tumors.
    Vlachos A
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):716-719. PubMed ID: 29222326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallmarks of ribosomopathies.
    Kampen KR; Sulima SO; Vereecke S; De Keersmaecker K
    Nucleic Acids Res; 2020 Feb; 48(3):1013-1028. PubMed ID: 31350888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth control and ribosomopathies.
    Teng T; Thomas G; Mercer CA
    Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribosomopathies: New Therapeutic Perspectives.
    Orgebin E; Lamoureux F; Isidor B; Charrier C; Ory B; Lézot F; Baud'huin M
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomopathies: human disorders of ribosome dysfunction.
    Narla A; Ebert BL
    Blood; 2010 Apr; 115(16):3196-205. PubMed ID: 20194897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.
    Kang J; Brajanovski N; Chan KT; Xuan J; Pearson RB; Sanij E
    Signal Transduct Target Ther; 2021 Aug; 6(1):323. PubMed ID: 34462428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomopathies and cancer: pharmacological implications.
    Temaj G; Saha S; Dragusha S; Ejupi V; Buttari B; Profumo E; Beqa L; Saso L
    Expert Rev Clin Pharmacol; 2022 Jun; 15(6):729-746. PubMed ID: 35787725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Ribosomes Translate Cancer.
    Sulima SO; Hofman IJF; De Keersmaecker K; Dinman JD
    Cancer Discov; 2017 Oct; 7(10):1069-1087. PubMed ID: 28923911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the mechanisms underlying human diseases in making ribosomes.
    Farley KI; Baserga SJ
    Biochem Soc Trans; 2016 Aug; 44(4):1035-44. PubMed ID: 27528749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of p53 in ribosomopathies.
    Fumagalli S; Thomas G
    Semin Hematol; 2011 Apr; 48(2):97-105. PubMed ID: 21435506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomopathies: how a common root can cause a tree of pathologies.
    Danilova N; Gazda HT
    Dis Model Mech; 2015 Sep; 8(9):1013-26. PubMed ID: 26398160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Biogenesis in Ribosomopathies.
    Sulima SO; Kampen KR; De Keersmaecker K
    Cells; 2019 Mar; 8(3):. PubMed ID: 30862070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When ribosomes go bad: diseases of ribosome biogenesis.
    Freed EF; Bleichert F; Dutca LM; Baserga SJ
    Mol Biosyst; 2010 Mar; 6(3):481-93. PubMed ID: 20174677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diamond-Blackfan anemia reveals the dark side of ribosome biogenesis].
    Aguissa-Touré AH; Da Costa L; Leblanc T; Tchernia G; Fribourg S; Gleizes PE
    Med Sci (Paris); 2009 Jan; 25(1):69-76. PubMed ID: 19154697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse diseases from a ubiquitous process: the ribosomopathy paradox.
    Armistead J; Triggs-Raine B
    FEBS Lett; 2014 May; 588(9):1491-500. PubMed ID: 24657617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomopathy-associated mutations cause proteotoxic stress that is alleviated by TOR inhibition.
    Recasens-Alvarez C; Alexandre C; Kirkpatrick J; Nojima H; Huels DJ; Snijders AP; Vincent JP
    Nat Cell Biol; 2021 Feb; 23(2):127-135. PubMed ID: 33495632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ribosomopathy genes during Xenopus tropicalis embryogenesis.
    Robson A; Owens ND; Baserga SJ; Khokha MK; Griffin JN
    BMC Dev Biol; 2016 Oct; 16(1):38. PubMed ID: 27784267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.